CHERRELL SHELLS: Open Payments
NPI 1033410451 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,286 in 82 payments from 16 companies in 2025. Trend: 2023 $372 · 2024 $888 · 2025 $1,286
Food & beverage: $1,286
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $367 |
| ABBVIE INC. | 25 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $207 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Novo Nordisk Inc | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Exact Sciences Corporation | 2 | $49 |
| PFIZER INC. | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
Products named: FANAPT, CAPLYTA, VRAYLAR, REXULTI, Wegovy, BREZTRI, UBRELVY, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
